grant

A platform for multi-modal single nucleus spatial genomics for molecular tumor analysis

Organization BROAD INSTITUTE, INC.Location CAMBRIDGE, UNITED STATESPosted 1 Aug 2024Deadline 31 Jul 2027
NIHUS FederalResearch GrantFY2025Aberrant ChromosomeAdoptionAffectAnti-Cancer AgentsAntineoplastic AgentsAntineoplastic DrugsAntineoplasticsBenchmarkingBest Practice AnalysisBiological MarkersBody TissuesCancer DrugCancersCell BodyCell CommunicationCell Communication and SignalingCell InteractionCell NucleusCell SignalingCell-to-Cell InteractionCellsChromatinChromosomal AberrationsChromosomal AbnormalitiesChromosomal AlterationsChromosome AberrationsChromosome AlterationsChromosome AnomaliesChromosome abnormalityClinicalCommunitiesComplexCytogenetic AberrationsCytogenetic AbnormalitiesDataDevelopmentDiagnosticDisease ProgressionDissociationEcologic SystemsEcological SystemsEcosystemEnvironmentEpigeneticEpigenetic ChangeEpigenetic MechanismEpigenetic ProcessEquipmentEvolutionExpression SignatureFibroblastsFutureGene ExpressionGene Expression ProfileGene TranscriptionGeneralized GrowthGenesGenetic DiversityGenetic TranscriptionGenetic VariationGenetic studyGenomeGenomicsGrowthHeritabilityHeterogeneityHistologicHistologicallyHumanImageImmuneImmune infiltratesImmune mediated therapyImmunesImmunologic ReceptorsImmunological ReceptorsImmunologically Directed TherapyImmunotherapyIn SituIndividualIntracellular Communication and SignalingIntratumoral heterogeneityMHC ReceptorMajor Histocompatibility Complex ReceptorMalignantMalignant - descriptorMalignant CellMalignant NeoplasmsMalignant TumorMeasurementMeasuresMetastasisMetastasizeMetastatic LesionMetastatic MassMetastatic NeoplasmMetastatic TumorMethylationModern ManMolecularNeoplasm MetastasisNeoplastic Disease Chemotherapeutic AgentsNon-MalignantNucleusOrganPathologyPhenotypeProtocolProtocols documentationRNA ExpressionResearch SpecimenResistanceResolutionScientistSecondary NeoplasmSecondary TumorSignal TransductionSignal Transduction SystemsSignalingSingle-Nucleus SequencingSlideSolid NeoplasmSolid TumorSomatic MutationSpecimenStandardizationT cell infiltrationT-Cell Antigen ReceptorsT-Cell ReceptorT-CellsT-LymphocyteTechnologyTherapeuticTimeTissue GrowthTissuesTrainingTranscriptionTreatment FailureTumor CellTumor ImmunityTumor-Specific Treatment AgentsValidationVariantVariationWorkanti-cancer druganti-tumor immunityantitumor immunitybenchmarkbio-markersbiologic markerbiological signal transductionbiomarkercancer cellcancer genomicscancer immunitycancer metastasiscancer microenvironmentcancer progressioncell typechromosomal defectchromosome defectcomputational frameworkcomputational pipelinescomputer frameworkdevelopmentaldisease controldisorder controlepigeneticallyepigenomicsgene expression patterngene expression signaturegenomic toolsglobal gene expressionglobal transcription profileheterogeneity in tumorsimage-based methodimagingimaging methodimaging modalityimmune cell infiltrateimmune receptorimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based therapiesimmune-based treatmentsimmuno therapyinnovateinnovationinnovativeintra-tumoral heterogeneityintratumor heterogeneityinventionmalignancymulti-modalitymultimodalitymultiomicsmultiple omicsneoplasm progressionneoplasm/cancerneoplastic cellneoplastic progressionnew drug treatmentsnew drugsnew pharmacological therapeuticnew technologynew therapeuticsnew therapynext generation therapeuticsnonmalignantnovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel technologiesnovel therapeuticsnovel therapyoncogenomicsontogenypanomicspersonalized diagnosispersonalized diagnosticsprecise diagnosticsprecision diagnosticsprognosticresistantresolutionsresponseresponse to therapyresponse to treatmentsNuc-Seqsingle cell genomicssingle nucleus RNA-sequencingsingle nucleus seqsingle-nucleus RNA-seqsnRNA sequencingsnRNA-seqsomatic variantspatial RNA sequencingspatial gene expression analysisspatial gene expression profilingspatial multiomicsspatial omicsspatial resolved transcriptome sequencingspatial transcriptome analysisspatial transcriptome profilingspatial transcriptome sequencingspatial transcriptomicsspatial tri-omicsspatially resolved transcriptomicsspatio transcriptomicssuccesstechnology platformtechnology systemtherapeutic responsetherapy failuretherapy responsethymus derived lymphocytetooltranscriptional profiletranscriptional signaturetranscriptometreatment responsetreatment responsivenesstumortumor cell metastasistumor growthtumor heterogeneitytumor microenvironmenttumor progressionvalidations
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary
Tumors reside within a complex multicellular ecosystem comprised of malignant and non-

malignant cells, where interacting cells and molecules are organized in space and time. The

diversity of these cells and their interactions affect cancer progression and drug response and

resistance, and present opportunities for more precise diagnostics and therapeutics. In this

proposal, we build upon our recent invention of Slide-tags, a single-cell spatial genomics

technology, to enable facile, spatial profiling of human tumors. We will apply Slide-tags across

a broad range of tumor specimens to enable future adoption with minimal training and equipment.

We will extend Slide-tags to measure not only transcription, but also epigenetic states and

genome variation within individual cells in the tumor microenvironment. Our novel computational

pipelines will allow the seamless integration of molecular, cellular and histological

understanding in tumors: they will enable the spatial localization of cell types within complex

tumor environments, the identification of spatially varying gene expression patterns driven by

pathology, as well as the organization of cellular niches. The innovations from this project will

yield a robust, multiomic spatial platform for the routine profiling of human tumors at scale.

Applying this platform will revolutionize our ability to discover changes in tumor spatial and

molecular organization during disease progression and treatment, provide new biomarkers for

diagnostics and prognostics, and highlight new therapeutic avenues.

Grant Number: 5R33CA291199-02
NIH Institute/Center: NIH

Principal Investigator: Fei Chen

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →